drugset / Trial / NCT02733133
Product Transference Study of Testagen™ TDS®-Testosterone
Phase 2
Not yet recruiting
96 enrolled
Transdermal Delivery Solutions Corp
Advanced Therapies Centre, The London Clinic · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study will assess the potential of Testagen® TDS-Testosterone to enable transfer of Testosterone to females coming in contact with skin to which Testagen® TDS-Testosterone has been applied and the potential of product to raise serum androgen levels in those women.
Timeline
- Start
- 2027-01-05
- Primary completion
- 2027-10
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 5 % | Topical |